PRODUCTS & INNOVATION
MILES WHITE TO STEP DOWN AS CEO AT THE END OF MARCH, REMAINS EXECUTIVE CHAIRMAN
Robert Ford, Abbott’s President & COO, appointed CEO.
Nov 13 2019
Miles White, Abbott’s iconic Chairman and CEO, is stepping down after a remarkable 21-year tenure, effective March 31, 2020. Robert Ford, Abbott’s President and COO, will become CEO at that time and Mr. White will remain Executive Chairman.
Two Decades of Transformation
Mr. White has strategically reshaped Abbott into one of the world’s leading health technology companies during his time as Chairman and CEO. He’s one of the longest-serving CEOs in healthcare and his achievements include internal advances such as FreeStyle Libre, the world’s leading continuous glucose monitor, and the Alinity family of diagnostics instruments, as well as hundreds more important technologies.
Mr. White is the architect behind Abbott’s ability to remain relevant and anticipate the future of healthcare through a combination of important internal investments and transactions. He’s responsible for creating two highly successful companies – Hospira in 2004 (which was acquired by Pfizer in 2015) and AbbVie in 2013, which is a Fortune 100 company today. He also spearheaded one of the most successful acquisitions in the pharmaceutical industry, purchasing BASF’s Knoll pharmaceutical business in 2001, which would lead to the world's leading drug, Humira. Most recently, he cemented Abbott’s leadership in medical devices and diagnostics with the additions of St. Jude Medical and Alere.
His bold strategic thinking and transformative actions have taken Abbott from what was a $75 billion company in 1999 with the majority of sales in the U.S., to the Abbott of today – one of the world’s most admired companies with a market cap of nearly $150 billion, business in more than 160 countries and 103,000 employees around the world.
To learn more about Mr. White’s most notable achievements during his tenure, click here.
Abbott Veteran Appointed as CEO
With this transition, Mr. Ford becomes the 13th CEO of Abbott in its 131-year history, all having been appointed from within, a testament to Abbott’s strong management philosophy and succession-planning discipline.
During Mr. Ford's 23 years at Abbott, he has served in many leadership roles within the company. As Executive Vice President of Medical Devices, he oversaw the integration of St. Jude Medical, Abbott's largest acquisition, and led Abbott's Diabetes Care business and the launch of FreeStyle Libre. He earned a bachelor's degree from Boston College and a master's degree in business administration from the University of California Berkeley, Haas School of Business.
To read, Mr. Ford’s biography, please click here.
To read the full news release on this announcement, please click here.
Your Best Care Demands Our Best Ideas
STEM Sister Feature: Alexis Roberts-McIntosh, Ph.D.
Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
The website you have requested also may not be optimized for your specific screen size.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.
The website that you have requested also may not be optimized for your screen size.